Wall Street analysts upgraded Stryker Corp (NYSE: SYK) after its Q4 report beat expectations, with strong sales and earnings growth projected for 2025.
Latest Ratings for SYK
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 2022 | Morgan Stanley | Maintains | Equal-Weight | |
| Jan 2022 | BTIG | Maintains | Buy | |
| Jan 2022 | SVB Leerink | Maintains | Outperform |
